iBio, Inc. Common Stock (IBIO) earnings · rev $100.0K
These earnings events as JSON? API free 100/dayiBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
This IBIO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
When the next IBIO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 75.0% from 2025-06-30 to 2026-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full IBIO research stays on the stock page; the tape stays on the quote page.
IBIO earnings FAQ
What are IBIO's latest revenue and net income?
Latest cached iBio, Inc. Common Stock (IBIO) revenue for Jun 30, 2026 was $100.0K. Net income was -$32.8M. Statements: https://lician.com/financials/ibio
What is IBIO's latest diluted EPS?
Latest cached iBio, Inc. Common Stock (IBIO) diluted EPS for Jun 30, 2026 was -$0.32.
What period does the latest IBIO earnings print cover?
The latest cached iBio, Inc. Common Stock (IBIO) earnings print covers Jun 30, 2026. The prior cached period on this page is Jun 30, 2025.
How did IBIO revenue change from the prior cached period?
Cached iBio, Inc. Common Stock (IBIO) revenue was down 75.0% from $400.0K (Jun 30, 2025) to $100.0K (Jun 30, 2026). Statements: https://lician.com/financials/ibio
Where are IBIO earnings listed?
Cached earnings facts for iBio, Inc. Common Stock (IBIO) are listed at https://lician.com/earnings/ibio. Statements: https://lician.com/financials/ibio
Not investment advice.